Global Tuberculosis Vaccine Treatment Market Growth 2023-2028

Report ID: 1319587 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Tuberculosis Vaccine Treatment Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Tuberculosis Vaccine Treatment by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Tuberculosis Vaccine Treatment by Country/Region, 2017, 2022 & 2028
    2.2 Tuberculosis Vaccine Treatment Segment by Type
        2.2.1 Immune Vaccine
        2.2.2 Therapy Vaccine
    2.3 Tuberculosis Vaccine Treatment Sales by Type
        2.3.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2022)
        2.3.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Tuberculosis Vaccine Treatment Sale Price by Type (2017-2022)
    2.4 Tuberculosis Vaccine Treatment Segment by Application
        2.4.1 Self-Procurement
        2.4.2 UNICEF
        2.4.3 Other
    2.5 Tuberculosis Vaccine Treatment Sales by Application
        2.5.1 Global Tuberculosis Vaccine Treatment Sale Market Share by Application (2017-2022)
        2.5.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Tuberculosis Vaccine Treatment Sale Price by Application (2017-2022)
3 Global Tuberculosis Vaccine Treatment by Company
    3.1 Global Tuberculosis Vaccine Treatment Breakdown Data by Company
        3.1.1 Global Tuberculosis Vaccine Treatment Annual Sales by Company (2020-2022)
        3.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Company (2020-2022)
    3.2 Global Tuberculosis Vaccine Treatment Annual Revenue by Company (2020-2022)
        3.2.1 Global Tuberculosis Vaccine Treatment Revenue by Company (2020-2022)
        3.2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Company (2020-2022)
    3.3 Global Tuberculosis Vaccine Treatment Sale Price by Company
    3.4 Key Manufacturers Tuberculosis Vaccine Treatment Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Tuberculosis Vaccine Treatment Product Location Distribution
        3.4.2 Players Tuberculosis Vaccine Treatment Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tuberculosis Vaccine Treatment by Geographic Region
    4.1 World Historic Tuberculosis Vaccine Treatment Market Size by Geographic Region (2017-2022)
        4.1.1 Global Tuberculosis Vaccine Treatment Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Tuberculosis Vaccine Treatment Annual Revenue by Geographic Region
    4.2 World Historic Tuberculosis Vaccine Treatment Market Size by Country/Region (2017-2022)
        4.2.1 Global Tuberculosis Vaccine Treatment Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Tuberculosis Vaccine Treatment Annual Revenue by Country/Region
    4.3 Americas Tuberculosis Vaccine Treatment Sales Growth
    4.4 APAC Tuberculosis Vaccine Treatment Sales Growth
    4.5 Europe Tuberculosis Vaccine Treatment Sales Growth
    4.6 Middle East & Africa Tuberculosis Vaccine Treatment Sales Growth
5 Americas
    5.1 Americas Tuberculosis Vaccine Treatment Sales by Country
        5.1.1 Americas Tuberculosis Vaccine Treatment Sales by Country (2017-2022)
        5.1.2 Americas Tuberculosis Vaccine Treatment Revenue by Country (2017-2022)
    5.2 Americas Tuberculosis Vaccine Treatment Sales by Type
    5.3 Americas Tuberculosis Vaccine Treatment Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Tuberculosis Vaccine Treatment Sales by Region
        6.1.1 APAC Tuberculosis Vaccine Treatment Sales by Region (2017-2022)
        6.1.2 APAC Tuberculosis Vaccine Treatment Revenue by Region (2017-2022)
    6.2 APAC Tuberculosis Vaccine Treatment Sales by Type
    6.3 APAC Tuberculosis Vaccine Treatment Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Tuberculosis Vaccine Treatment by Country
        7.1.1 Europe Tuberculosis Vaccine Treatment Sales by Country (2017-2022)
        7.1.2 Europe Tuberculosis Vaccine Treatment Revenue by Country (2017-2022)
    7.2 Europe Tuberculosis Vaccine Treatment Sales by Type
    7.3 Europe Tuberculosis Vaccine Treatment Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Tuberculosis Vaccine Treatment by Country
        8.1.1 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Tuberculosis Vaccine Treatment Revenue by Country (2017-2022)
    8.2 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Type
    8.3 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccine Treatment
    10.3 Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
    10.4 Industry Chain Structure of Tuberculosis Vaccine Treatment
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Tuberculosis Vaccine Treatment Distributors
    11.3 Tuberculosis Vaccine Treatment Customer
12 World Forecast Review for Tuberculosis Vaccine Treatment by Geographic Region
    12.1 Global Tuberculosis Vaccine Treatment Market Size Forecast by Region
        12.1.1 Global Tuberculosis Vaccine Treatment Forecast by Region (2023-2028)
        12.1.2 Global Tuberculosis Vaccine Treatment Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Tuberculosis Vaccine Treatment Forecast by Type
    12.7 Global Tuberculosis Vaccine Treatment Forecast by Application
13 Key Players Analysis
    13.1 Merck
        13.1.1 Merck Company Information
        13.1.2 Merck Tuberculosis Vaccine Treatment Product Offered
        13.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Merck Main Business Overview
        13.1.5 Merck Latest Developments
    13.2 Japan BCG Lab
        13.2.1 Japan BCG Lab Company Information
        13.2.2 Japan BCG Lab Tuberculosis Vaccine Treatment Product Offered
        13.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Japan BCG Lab Main Business Overview
        13.2.5 Japan BCG Lab Latest Developments
    13.3 Serum Institute of India
        13.3.1 Serum Institute of India Company Information
        13.3.2 Serum Institute of India Tuberculosis Vaccine Treatment Product Offered
        13.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Serum Institute of India Main Business Overview
        13.3.5 Serum Institute of India Latest Developments
    13.4 AJ Vaccines
        13.4.1 AJ Vaccines Company Information
        13.4.2 AJ Vaccines Tuberculosis Vaccine Treatment Product Offered
        13.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 AJ Vaccines Main Business Overview
        13.4.5 AJ Vaccines Latest Developments
    13.5 BioFarma
        13.5.1 BioFarma Company Information
        13.5.2 BioFarma Tuberculosis Vaccine Treatment Product Offered
        13.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 BioFarma Main Business Overview
        13.5.5 BioFarma Latest Developments
    13.6 GreenSignal Bio Pharma
        13.6.1 GreenSignal Bio Pharma Company Information
        13.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Offered
        13.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 GreenSignal Bio Pharma Main Business Overview
        13.6.5 GreenSignal Bio Pharma Latest Developments
    13.7 China National Biotec
        13.7.1 China National Biotec Company Information
        13.7.2 China National Biotec Tuberculosis Vaccine Treatment Product Offered
        13.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 China National Biotec Main Business Overview
        13.7.5 China National Biotec Latest Developments
    13.8 Biomed Lublin
        13.8.1 Biomed Lublin Company Information
        13.8.2 Biomed Lublin Tuberculosis Vaccine Treatment Product Offered
        13.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Biomed Lublin Main Business Overview
        13.8.5 Biomed Lublin Latest Developments
    13.9 Taj Pharmaceuticals
        13.9.1 Taj Pharmaceuticals Company Information
        13.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Offered
        13.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Taj Pharmaceuticals Main Business Overview
        13.9.5 Taj Pharmaceuticals Latest Developments
    13.10 Ataulpho de Paiva
        13.10.1 Ataulpho de Paiva Company Information
        13.10.2 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Offered
        13.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Ataulpho de Paiva Main Business Overview
        13.10.5 Ataulpho de Paiva Latest Developments
    13.11 IVAC
        13.11.1 IVAC Company Information
        13.11.2 IVAC Tuberculosis Vaccine Treatment Product Offered
        13.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 IVAC Main Business Overview
        13.11.5 IVAC Latest Developments
    13.12 Queen Saovabha Mem. Inst
        13.12.1 Queen Saovabha Mem. Inst Company Information
        13.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Offered
        13.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Queen Saovabha Mem. Inst Main Business Overview
        13.12.5 Queen Saovabha Mem. Inst Latest Developments
    13.13 Microgen
        13.13.1 Microgen Company Information
        13.13.2 Microgen Tuberculosis Vaccine Treatment Product Offered
        13.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Microgen Main Business Overview
        13.13.5 Microgen Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Tuberculosis Vaccine Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Tuberculosis Vaccine Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Immune Vaccine
    Table 4. Major Players of Therapy Vaccine
    Table 5. Global Tuberculosis Vaccine Treatment Sales by Type (2017-2022) & (K Dose)
    Table 6. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2022)
    Table 7. Global Tuberculosis Vaccine Treatment Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2017-2022)
    Table 9. Global Tuberculosis Vaccine Treatment Sale Price by Type (2017-2022) & (USD/K Dose)
    Table 10. Global Tuberculosis Vaccine Treatment Sales by Application (2017-2022) & (K Dose)
    Table 11. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2022)
    Table 12. Global Tuberculosis Vaccine Treatment Revenue by Application (2017-2022)
    Table 13. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2017-2022)
    Table 14. Global Tuberculosis Vaccine Treatment Sale Price by Application (2017-2022) & (USD/K Dose)
    Table 15. Global Tuberculosis Vaccine Treatment Sales by Company (2020-2022) & (K Dose)
    Table 16. Global Tuberculosis Vaccine Treatment Sales Market Share by Company (2020-2022)
    Table 17. Global Tuberculosis Vaccine Treatment Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Tuberculosis Vaccine Treatment Revenue Market Share by Company (2020-2022)
    Table 19. Global Tuberculosis Vaccine Treatment Sale Price by Company (2020-2022) & (USD/K Dose)
    Table 20. Key Manufacturers Tuberculosis Vaccine Treatment Producing Area Distribution and Sales Area
    Table 21. Players Tuberculosis Vaccine Treatment Products Offered
    Table 22. Tuberculosis Vaccine Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Tuberculosis Vaccine Treatment Sales by Geographic Region (2017-2022) & (K Dose)
    Table 26. Global Tuberculosis Vaccine Treatment Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Tuberculosis Vaccine Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Tuberculosis Vaccine Treatment Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Tuberculosis Vaccine Treatment Sales by Country/Region (2017-2022) & (K Dose)
    Table 30. Global Tuberculosis Vaccine Treatment Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Tuberculosis Vaccine Treatment Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Tuberculosis Vaccine Treatment Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Tuberculosis Vaccine Treatment Sales by Country (2017-2022) & (K Dose)
    Table 34. Americas Tuberculosis Vaccine Treatment Sales Market Share by Country (2017-2022)
    Table 35. Americas Tuberculosis Vaccine Treatment Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Tuberculosis Vaccine Treatment Revenue Market Share by Country (2017-2022)
    Table 37. Americas Tuberculosis Vaccine Treatment Sales by Type (2017-2022) & (K Dose)
    Table 38. Americas Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2022)
    Table 39. Americas Tuberculosis Vaccine Treatment Sales by Application (2017-2022) & (K Dose)
    Table 40. Americas Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2022)
    Table 41. APAC Tuberculosis Vaccine Treatment Sales by Region (2017-2022) & (K Dose)
    Table 42. APAC Tuberculosis Vaccine Treatment Sales Market Share by Region (2017-2022)
    Table 43. APAC Tuberculosis Vaccine Treatment Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Tuberculosis Vaccine Treatment Revenue Market Share by Region (2017-2022)
    Table 45. APAC Tuberculosis Vaccine Treatment Sales by Type (2017-2022) & (K Dose)
    Table 46. APAC Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2022)
    Table 47. APAC Tuberculosis Vaccine Treatment Sales by Application (2017-2022) & (K Dose)
    Table 48. APAC Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2022)
    Table 49. Europe Tuberculosis Vaccine Treatment Sales by Country (2017-2022) & (K Dose)
    Table 50. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country (2017-2022)
    Table 51. Europe Tuberculosis Vaccine Treatment Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country (2017-2022)
    Table 53. Europe Tuberculosis Vaccine Treatment Sales by Type (2017-2022) & (K Dose)
    Table 54. Europe Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2022)
    Table 55. Europe Tuberculosis Vaccine Treatment Sales by Application (2017-2022) & (K Dose)
    Table 56. Europe Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Country (2017-2022) & (K Dose)
    Table 58. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Tuberculosis Vaccine Treatment Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Type (2017-2022) & (K Dose)
    Table 62. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Tuberculosis Vaccine Treatment Sales by Application (2017-2022) & (K Dose)
    Table 64. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Tuberculosis Vaccine Treatment
    Table 66. Key Market Challenges & Risks of Tuberculosis Vaccine Treatment
    Table 67. Key Industry Trends of Tuberculosis Vaccine Treatment
    Table 68. Tuberculosis Vaccine Treatment Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Tuberculosis Vaccine Treatment Distributors List
    Table 71. Tuberculosis Vaccine Treatment Customer List
    Table 72. Global Tuberculosis Vaccine Treatment Sales Forecast by Region (2023-2028) & (K Dose)
    Table 73. Global Tuberculosis Vaccine Treatment Sales Market Forecast by Region
    Table 74. Global Tuberculosis Vaccine Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Tuberculosis Vaccine Treatment Sales Forecast by Country (2023-2028) & (K Dose)
    Table 77. Americas Tuberculosis Vaccine Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Tuberculosis Vaccine Treatment Sales Forecast by Region (2023-2028) & (K Dose)
    Table 79. APAC Tuberculosis Vaccine Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Tuberculosis Vaccine Treatment Sales Forecast by Country (2023-2028) & (K Dose)
    Table 81. Europe Tuberculosis Vaccine Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Tuberculosis Vaccine Treatment Sales Forecast by Country (2023-2028) & (K Dose)
    Table 83. Middle East & Africa Tuberculosis Vaccine Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Tuberculosis Vaccine Treatment Sales Forecast by Type (2023-2028) & (K Dose)
    Table 85. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Tuberculosis Vaccine Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Tuberculosis Vaccine Treatment Sales Forecast by Application (2023-2028) & (K Dose)
    Table 89. Global Tuberculosis Vaccine Treatment Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Tuberculosis Vaccine Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Tuberculosis Vaccine Treatment Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Merck Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 93. Merck Tuberculosis Vaccine Treatment Product Offered
    Table 94. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 95. Merck Main Business
    Table 96. Merck Latest Developments
    Table 97. Japan BCG Lab Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 98. Japan BCG Lab Tuberculosis Vaccine Treatment Product Offered
    Table 99. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 100. Japan BCG Lab Main Business
    Table 101. Japan BCG Lab Latest Developments
    Table 102. Serum Institute of India Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 103. Serum Institute of India Tuberculosis Vaccine Treatment Product Offered
    Table 104. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 105. Serum Institute of India Main Business
    Table 106. Serum Institute of India Latest Developments
    Table 107. AJ Vaccines Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 108. AJ Vaccines Tuberculosis Vaccine Treatment Product Offered
    Table 109. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 110. AJ Vaccines Main Business
    Table 111. AJ Vaccines Latest Developments
    Table 112. BioFarma Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 113. BioFarma Tuberculosis Vaccine Treatment Product Offered
    Table 114. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 115. BioFarma Main Business
    Table 116. BioFarma Latest Developments
    Table 117. GreenSignal Bio Pharma Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 118. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Offered
    Table 119. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 120. GreenSignal Bio Pharma Main Business
    Table 121. GreenSignal Bio Pharma Latest Developments
    Table 122. China National Biotec Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 123. China National Biotec Tuberculosis Vaccine Treatment Product Offered
    Table 124. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 125. China National Biotec Main Business
    Table 126. China National Biotec Latest Developments
    Table 127. Biomed Lublin Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 128. Biomed Lublin Tuberculosis Vaccine Treatment Product Offered
    Table 129. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 130. Biomed Lublin Main Business
    Table 131. Biomed Lublin Latest Developments
    Table 132. Taj Pharmaceuticals Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 133. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Offered
    Table 134. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 135. Taj Pharmaceuticals Main Business
    Table 136. Taj Pharmaceuticals Latest Developments
    Table 137. Ataulpho de Paiva Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 138. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Offered
    Table 139. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 140. Ataulpho de Paiva Main Business
    Table 141. Ataulpho de Paiva Latest Developments
    Table 142. IVAC Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 143. IVAC Tuberculosis Vaccine Treatment Product Offered
    Table 144. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 145. IVAC Main Business
    Table 146. IVAC Latest Developments
    Table 147. Queen Saovabha Mem. Inst Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 148. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Offered
    Table 149. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 150. Queen Saovabha Mem. Inst Main Business
    Table 151. Queen Saovabha Mem. Inst Latest Developments
    Table 152. Microgen Basic Information, Tuberculosis Vaccine Treatment Manufacturing Base, Sales Area and Its Competitors
    Table 153. Microgen Tuberculosis Vaccine Treatment Product Offered
    Table 154. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2022)
    Table 155. Microgen Main Business
    Table 156. Microgen Latest Developments
List of Figures
    Figure 1. Picture of Tuberculosis Vaccine Treatment
    Figure 2. Tuberculosis Vaccine Treatment Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Tuberculosis Vaccine Treatment Sales Growth Rate 2017-2028 (K Dose)
    Figure 7. Global Tuberculosis Vaccine Treatment Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Tuberculosis Vaccine Treatment Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Immune Vaccine
    Figure 10. Product Picture of Therapy Vaccine
    Figure 11. Global Tuberculosis Vaccine Treatment Sales Market Share by Type in 2021
    Figure 12. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2017-2022)
    Figure 13. Tuberculosis Vaccine Treatment Consumed in Self-Procurement
    Figure 14. Global Tuberculosis Vaccine Treatment Market: Self-Procurement (2017-2022) & (K Dose)
    Figure 15. Tuberculosis Vaccine Treatment Consumed in UNICEF
    Figure 16. Global Tuberculosis Vaccine Treatment Market: UNICEF (2017-2022) & (K Dose)
    Figure 17. Tuberculosis Vaccine Treatment Consumed in Other
    Figure 18. Global Tuberculosis Vaccine Treatment Market: Other (2017-2022) & (K Dose)
    Figure 19. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2017-2022)
    Figure 20. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application in 2021
    Figure 21. Tuberculosis Vaccine Treatment Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global Tuberculosis Vaccine Treatment Revenue Market Share by Company in 2021
    Figure 23. Global Tuberculosis Vaccine Treatment Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global Tuberculosis Vaccine Treatment Revenue Market Share by Geographic Region in 2021
    Figure 25. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2017-2022)
    Figure 26. Global Tuberculosis Vaccine Treatment Revenue Market Share by Country/Region in 2021
    Figure 27. Americas Tuberculosis Vaccine Treatment Sales 2017-2022 (K Dose)
    Figure 28. Americas Tuberculosis Vaccine Treatment Revenue 2017-2022 ($ Millions)
    Figure 29. APAC Tuberculosis Vaccine Treatment Sales 2017-2022 (K Dose)
    Figure 30. APAC Tuberculosis Vaccine Treatment Revenue 2017-2022 ($ Millions)
    Figure 31. Europe Tuberculosis Vaccine Treatment Sales 2017-2022 (K Dose)
    Figure 32. Europe Tuberculosis Vaccine Treatment Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa Tuberculosis Vaccine Treatment Sales 2017-2022 (K Dose)
    Figure 34. Middle East & Africa Tuberculosis Vaccine Treatment Revenue 2017-2022 ($ Millions)
    Figure 35. Americas Tuberculosis Vaccine Treatment Sales Market Share by Country in 2021
    Figure 36. Americas Tuberculosis Vaccine Treatment Revenue Market Share by Country in 2021
    Figure 37. United States Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC Tuberculosis Vaccine Treatment Sales Market Share by Region in 2021
    Figure 42. APAC Tuberculosis Vaccine Treatment Revenue Market Share by Regions in 2021
    Figure 43. China Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country in 2021
    Figure 50. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country in 2021
    Figure 51. Germany Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa Tuberculosis Vaccine Treatment Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country in 2021
    Figure 58. Egypt Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Tuberculosis Vaccine Treatment Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of Tuberculosis Vaccine Treatment in 2021
    Figure 64. Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
    Figure 65. Industry Chain Structure of Tuberculosis Vaccine Treatment
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Tuberculosis Vaccine Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Tuberculosis Vaccine Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Tuberculosis Vaccine Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports